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More than 150 years ago, the German pathologist Rudolf Ludwig Karl Virchow (1821-
1901) described the finding of involvement of the left supraclavicular node by gastric 
cancer.1 It is now known that a number of abdominal and thoracic malignancies have 
a propensity to metastasize to this anatomic site, which is commonly referred to as 
Virchow’s node. Cancers known to spread to Virchow’s node include malignancies of 
the lung, pancreas, esophagus, adenonocarcinoma of the gastric corpus, kidney, 
ovary, testicle, stomach, corpus uteri, cervix uteri, colon cancer and rectum.2 
Metastasis to Virchow’s node has also been reported in men with prostate cancer, 
however this has generally been observed at a low frequency of only 0.5%.3 
 
In recent years, Positron Emission Tomography (PET) radiotracers targeting 
prostate-specific membrane antigen (PSMA), including 68Ga-PSMA-11 and 18F-
DCFPyL, have been increasingly used to image men with prostate cancer.4, 5 PET 
imaging with these agents offers greatly improved sensitivity over conventional 
imaging modalities for detecting low volume sites of tumor burden.6, 7 Because of the 
outstanding sensitivity afforded by PSMA-targeted PET, it can be directly visualized 
that many patients with advanced prostate cancer can harbor disease within 
Virchow’s node (Fig. 1).3, 7-10  This observation has served as an opportunity to re-
explore the exemplary life and career of Rudolf Ludwig Karl Virchow.     
 
Rudolf Ludwig Karl Virchow – “Pope of Medicine” in the 19th Century and 
Social Reformer 
Remembered as the most influential pathologist in the nineteenth century, Virchow 
was also famous as a liberal politician and one of the leaders of the “Deutsche 
Fortschrittspartei” (German Progressive Party), the liberal political movement in 
Germany. In a time of competing political ideologies including nationalism, socialism 
and conservatism, the “Progressive Party” led the opposition to the constitutional 
forces by Prime Minister of Prussia Otto von Bismarck. However, due to his role in 
the 1848 “Märzrevolution” (March Revolution), Virchow was finally forced to leave 
Berlin and was subsequently appointed the First Chair of Pathological Anatomy at 
the University of Würzburg in 1849.11, 12 Five years later the Charité Berlin re-
assigned him as the first Chair of Pathological Anatomy and Physiology due to his 
increasing international popularity and reputation.11, 13, 14 Known as the father of 
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cellular pathology, Virchow established the journal “Archiv für pathologische 
Anatomie und Physiologie und für klinische Medizin” in close collaboration with his 
friend Benno Reinhardt (1819-1852). Pursuing the goal of transforming the esoteric 
medicine in Germany to a scientific discipline, this journal is still with us today and is 
now known as “Virchows Archiv”, the official journal of the European Society of 
Pathology.15  
 
As a broadly influential thinker of his day, Virchow’s career in social science remains 
equally as remarkable as his work in medicine. More specifically, he is credited with 
founding the newspaper “Die medicinische Reform” (Medical Reform), popularizing 
the term “social medicine,” and promoting the concept of physicians serving as 
“attorney[s] of the poor.” One of his most famous contributions in medical literature is 
the “Report on Typhus Epidemic in Upper Silesia.” Asked by the Education Minister 
of Prussia, Virchow investigated the 1848 typhus epidemic in this poor rural Prussian 
province (now within the borders of Poland) and stated that Prussian authorities had 
failed in preventing the outbreak of this devastating disease. Outlining a revolutionary 
program, Virchow emphasized the urgent need for improvement of social conditions 
in this area, i.e. democratic self-government, disestablishment of the Catholic 
Church, and agricultural co-operatives.16-18 Another example of his contribution to 
social medicine is his report “Reinigung und Entwässerung Berlins” in which through 
a combination of political power and scientific knowledge he pushed the construction 
of the first sewer system of Berlin. 19  
 
Virchow and his Aftermath 
With close to 2000 publications, Virchow has made major contributions to the field of 
cellular pathology and should be remembered for the introduction of certain medical 
terms that are still in use today: Virchow defined the term “embolus” along with its 
thombosis mechanism, the word “amyloid” and its reaction with iodine and sulphuric 
acid in the brain, as well as the term “granuloma.”11, 20, 21  
 
The Virchow Node 
Indisputably, the first description of an enlargend supraclavicular lymph node 
involved in metastatic malignancies dates back to Virchow. In 1848, he outlined in his 
article “Zur Diagnose der Krebse im Unterleibe“ (Fig. 2):  
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“(…) namentlich 
 bei Krebsen des Magens, des Pankreas, der Eierstöcke, etc., wie sich der Prozess 
allmählich von den Lymphdrüsen des Unterleibs auf die im hinteren Mediastinum 
neben dem Ductus thoracicus gelegenen Drüsen fortsetzt und endlich bis auf die 
Jugulardrüsen fortkriecht, welche rings um die Einmündungsstelle des Ductus 
thoracicus (in der linken Supraclavicular-Grube) (…)”1 
 
This part has been translated by Morgenstern in 1979: 
 
“(. . .) Thus, particularly in cancer of the stomach, the pancreas, the ovaries, etc. the 
process gradually spreads from the glands of the lower abdomen to the glands in the 
posterior mediastinum along the ductus thoracicus and finally involves the jugular 
glands around the junction of the ductus thoracicus (in the left supraclavicular fossa)  
(. . .). “22 
 
In 1889, Charles-Emile Troisier (1844-1919) also reported on the findings in 27 cases 
of gastric carcinoma and noted a palpable, hard, left supraclavicular node being 
present.23 It has been thought that the cancerous enlargement of the left 
supraclavicular node at the junction of the thoracic duct and the left subclavian vein 
and the tendency of gastric carcinoma to metastasize towards this region is related to 
tumor emboli migration through the thoracic duct. The thoracic duct is a continuation 
of the cisterna chyli at the L1 level, which then enters the thoracic cavity through the 
aortic hiatus and continues in the posterior mediastinum between the aorta and 
azygos vein.24 The duct drains lymphatic fluid into the angle of the left subclavian and 
internal jugular vein. The end node of the thoracic duct is the so-called Virchow Node 
and is located near or at this jugulo-subclavian venous junction.25 The involvement of 
the Virchow Node by metastasis can be seen in several types of cancer. Viacava et 
al. investigated 4,365 patients suffering from abdominal and thoracic tumors and 
found an enlarged Virchow Node in 2.8% of the patients.2 The highest frequency was 
observed in patients suffering from cancers of the lung, pancreas, esophagus, 
kidney, ovary, testicle, stomach, prostate, corpus uteri, cervix uteri, and rectum.2 
Despite its first description more than 150 years ago, the underlying anatomy of the 
thoracic duct end node has just been investigated more recently. More specifically, in 
2005 Mizutani and co-workers found that the thoracic duct is divided into 3-10 
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several collateral ducts and these ducts surround the Virchow Node.25  
 
Conclusion  
The first description of pathological enlargement of the left supraclavicular node by 
gastric cancer was provided by Virchow in 1848. A number of other malignancies are 
now known to spread to this anatomic site. While prostate cancer has not classically 
been thought to have a propensity for metastasizing to the Virchow Node, advances 
in molecular imaging have revealed the contrary. The prevalent involvement of the 
Virchow Node by prostate cancer has likely been underestimated in the past due to 
our inability to effectively characterize non-pathologically enlarged lymph nodes in 
this patient population. More than one and a half centuries after its first description, 
this in vivo detection of supraclavicular lymphadenopathy using prostate molecular 
imaging emphasizes the importance of the insightful and visionary work of Dr. 
Virchow. Further studies on the nature of the prostate cancer cells that are 
disseminated to the Virchow node may shed light on the mechanism of prostate 
cancer metastases, the transition from the oligometastatic to the polymetastatic state, 
and the tumor microenvironment needed to maintain prostate cancer cells within this 
unique lymph node. However, if one might consider a molecular imaging approach to 
obtain specimen from the Virchow Node (e.g., by performing PET-guided biopsies), 
the costs for those type of studies have to be taken into account and the risk should 









Figure 1. Images from a 18F-DCFPyL PET/CT scan in a 57-year-old man with 
untreated, biopsy-proven Gleason 5+4=9 prostate cancer with serum prostate 
specific antigen level of 109.2 ng/mL. (A) Whole body maximum intensity projection 
image demonstrates extensive adenopathy including a left supraclavicular Virchow 
Node (red arrow) as well as radiotracer-avid lymph nodes in left cervical levels IV and 
V, the mediastinum (red arrowhead), the retrocrural space (thin red arrow), the 
retroperitoneum (double thin red arrow), and the pelvis. (B) CT, (C) PET, and (D) 
PET/CT axial images at the level of the Virchow Node show that its small size (5 mm 
short axis, red arrows) would make it occult on conventional anatomic imaging and 
indicate the importance of molecular imaging with a PSMA-targeted agent to uncover 
this site of disease. Additional axial PET/CT images through (E) the mediastinum, (F) 
the retrocrural space, and (G) the retroperitoneum demonstrate additional involved 
lymph nodes (red arrowhead in (E), thin red arrow in (F), and double thin red arrow in 
(G)) and suggest a pathway for involvement of the Virchow Node; i.e. the cancer 
likely spread up the cisterna chyli in the proximity of the retrocrural node, then 
through the thoracic duct where it was able to establish sites of metastasis in both 
the mediastinum and left supraclavicular fossa. 
 
Figure 2. (A) Original german article, “Zur Diagnose der Krebse im Unterleibe” by 
Rudolf Karl Ludwig Virchow, published in “Medicinische Reform” (45:248) in 1848. 
The article is within the section titled “Kleinere Mittheilungen” (Brief Communication). 
Description of the Virchow Node and the name of the author (Virchow) were both 
highlighted by a red frame. (B) Excerpt of “Zur Diagnose der Krebse im Unterleibe” 
showing the magnified paragraph of the Virchow Node description (upper red frame). 
The lower red frame highlights the name „Dr. Rud. Virchow“, acting as the author of 
the article and as the editor-in-chief of the journal “Medicinische Reform”. 
(Universitätsbibliothek Heidelberg / Zur Diagnose der Krebse im Unterleibe / 
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